{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:18:43Z","timestamp":1793495923120,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.ahj.2008.01.031","type":"journal-article","created":{"date-parts":[[2008,4,26]],"date-time":"2008-04-26T15:09:02Z","timestamp":1209222542000},"page":"791-805","source":"Crossref","is-referenced-by-count":101,"title":["Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: A meta-analysis"],"prefix":"10.1016","volume":"155","author":[{"given":"Saravanan","family":"Balamuthusamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasikanth","family":"Adigopula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Jalandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Hathiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earl","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2008.01.031_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2008.01.031_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.01.031_bib3","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.01.031_bib4","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s000180050490","article-title":"Beyond blood pressure: new roles for angiotensin II","volume":"56","author":"Lucius","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ahj.2008.01.031_bib5","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","article-title":"Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability","volume":"101","author":"Schieffer","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.01.031_bib6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.ki.5000026","article-title":"Microalbuminuria in patients with previous myocardial infarction","volume":"69","author":"Henareh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2008.01.031_bib7","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1136\/bmj.294.6588.1651","article-title":"Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus","volume":"294","author":"Borch-Johnsen","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ahj.2008.01.031_bib8","first-page":"236","article-title":"A ten-year prospective study, 1964-1974, of cardiovascular risk factors in men and women from the Glostrup population born in 1914. Multivariate analyses","volume":"28","author":"Schroll","year":"1981","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.ahj.2008.01.031_bib9","first-page":"265","article-title":"ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study","volume":"9","author":"Maschio","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ahj.2008.01.031_bib10","doi-asserted-by":"crossref","unstructured":"Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. Adults, 1999 to 2000. J Am Soc Nephrol. doi:10.1681\/ASN.2004070539.","DOI":"10.1681\/ASN.2004070539"},{"key":"10.1016\/j.ahj.2008.01.031_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1053\/j.ajkd.2006.08.004","article-title":"Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) trial","volume":"48","author":"Norris","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2008.01.031_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.7326\/0003-4819-144-3-200602070-00005","article-title":"Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate","volume":"144","author":"Rahman","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2008.01.031_bib13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/ki.1996.480","article-title":"Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy","volume":"50","author":"Bakris","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2008.01.031_bib14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1046\/j.1523-1755.2000.00879.x","article-title":"Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients","volume":"57","author":"Chan","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2008.01.031_bib15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/bmj.37970.629537.0D","article-title":"Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)","volume":"328","author":"Marre","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2008.01.031_bib16","first-page":"S58","article-title":"Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?","volume":"63","author":"van Essen","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ahj.2008.01.031_bib17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.309.6958.833","article-title":"Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure","volume":"309","author":"Hannedouche","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2008.01.031_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group","volume":"334","author":"Maschio","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.01.031_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2008.01.031_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08037059509077575","article-title":"ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension","volume":"4","author":"Himmelmann","year":"1995","journal-title":"Blood Press"},{"key":"10.1016\/j.ahj.2008.01.031_bib21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"1993","journal-title":"NEJM"},{"key":"10.1016\/j.ahj.2008.01.031_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0272-6386(96)90158-4","article-title":"Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial","volume":"27","author":"Ihle","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2008.01.031_bib23","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2337\/diacare.20.10.1576","article-title":"Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria","volume":"20","author":"Ahmad","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2008.01.031_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10157-003-0241-3","volume":"7","author":"Iino","year":"2003","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ahj.2008.01.031_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ajh\/5.7.423","article-title":"Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial","volume":"5","author":"Kamper","year":"1992","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2008.01.031_bib26","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/ndt\/gfg284","article-title":"Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial","volume":"18","author":"Praga","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ahj.2008.01.031_bib27","doi-asserted-by":"crossref","first-page":"c139","DOI":"10.1159\/000086714","article-title":"A prospective open-label randomised trial of quinapril and\/or amlodipine in progressive non-diabetic renal failure","volume":"101","author":"MacGregor","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ahj.2008.01.031_bib28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2337\/diab.46.7.1182","article-title":"Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy","volume":"46","author":"Nielsen","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.ahj.2008.01.031_bib29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"NEJM"},{"key":"10.1016\/j.ahj.2008.01.031_bib30","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00004872-200110000-00023","article-title":"Efecto del tratamiento antihipertensivo Sobre la Progresi\u00f3n de la Insuficiencia RenAL en pacientes no diab\u00e9ticos. A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease","volume":"19","author":"Marin","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2008.01.031_bib31","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.01.031_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"NEJM"},{"key":"10.1016\/j.ahj.2008.01.031_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/ki.1992.309","article-title":"Long-term comparison between captopril and nifedipine in the progression of renal insufficiency","volume":"42","author":"Zucchelli","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2008.01.031_bib34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ndt\/16.5.961","article-title":"Effect of lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies","volume":"16","author":"Cinotti","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ahj.2008.01.031_bib35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3317\/jraas.2000.030","article-title":"Neurohumoral blockade in CHF management","volume":"1","author":"Willenbrock","year":"2000","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ahj.2008.01.031_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2281.2001.00371.x","article-title":"Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives","volume":"21","author":"Kjaer","year":"2001","journal-title":"Clin Physiol"},{"key":"10.1016\/j.ahj.2008.01.031_bib37","first-page":"34","article-title":"Arterial hypertension and systolic left ventricular dysfunction: therapeutic approach","volume":"52","author":"Anguita S\u00e1nchez","year":"1999","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.ahj.2008.01.031_bib38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.01.031_bib39","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.HYP.0000174591.42889.a2","article-title":"Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention","volume":"46","author":"Verdecchia","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2008.01.031_bib40","first-page":"184","article-title":"Statins decrease the risk of acute myocardial infarction and coronary heart disease mortality in patients with renal failure: a meta-analysis: ACC. Poster Session","volume":"49","author":"Balamuthusamy","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.01.031_bib41","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circulation Research"},{"key":"10.1016\/j.ahj.2008.01.031_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"}],"updated-by":[{"DOI":"10.1016\/j.ahj.2009.01.010","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000}}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308001361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308001361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T13:50:20Z","timestamp":1546091420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870308001361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0002870308001361"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2008.01.031","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}